24/7 Customer Support

News

January 2025
FDA Approves Monthly Maintenance Dosing for Alzheimer's Drug Leqembi

The U.S. Food and Drug Administration (FDA) has approved the monthly maintenance dosing of Leqembi, an Alzheimer's drug developed by Japan-based Eisai (4523.T) in partnership with Biogen. This announcement marks a significant development in the treatment of Alzheimer's disease.

Background on Leqembi

Leqembi received standard U.S. approval in 2023 after clinical...

Read More
January 2025
Mitsubishi Plans to Launch a New Electric Vehicle in 2026

Mitsubishi, while one of the smaller Japanese automakers, has long been working on its electrification plans to stay relevant in the rapidly evolving automotive industry. The company has made several bold announcements in the past about its shift toward electrified vehicles, signaling its ambition to keep up with the competition.

Mitsubishi’s...

Read More
January 2025
Immuneel Therapeutics Introduces Qartemi, India’s First CAR T-Cell Therapy for B-NHL

Immuneel Therapeutics has launched Qartemi, a cutting-edge CAR T-cell therapy aimed at treating adult patients with relapsed or refractory B-cell Non-Hodgkin Lymphoma (B-NHL). This personalized therapy marks a significant milestone in India's cancer treatment landscape, particularly in the realm of immunotherapy.

Addressing a Critical Gap in Cancer Care

The company states...

Read More
January 2025
AWS Announces US$ 8.3 Billion Investment in Cloud Infrastructure in India

Amazon Web Services (AWS) has unveiled a substantial plan to invest $8.3 billion into cloud infrastructure in the AWS Asia-Pacific (Mumbai) Region, located in Maharashtra. This initiative aims to significantly expand AWS’s cloud computing capacity in India and cater to the growing demand for cloud services nationwide.

The investment is projected...

Read More